Navigation Links
Nektar to Announce Financial Results for the Third Quarter of 2010 on Thursday, November 4, 2010, After Close of U.S.-Based Financial Markets
Date:10/28/2010

SAN CARLOS, Calif., Oct. 28 /PRNewswire-FirstCall/ -- Nektar Therapeutics (Nasdaq: NKTR) will announce its financial results for the third quarter ended September 30, 2010 on Thursday, November 4, 2010, after the close of U.S.-based financial markets. Howard Robin, president and chief executive officer, will host a conference call to review the results beginning at 5:00 p.m. Eastern Time (ET)/2:00 p.m. Pacific Time (PT).

The press release and a live audio-only Webcast of the conference call can be accessed through a link that is posted on the home page and Investor Relations section of the Nektar website: http://www.nektar.com. The web broadcast of the conference call will be available for replay through Friday, November 19, 2010. To access the conference call, follow these instructions:Dial: (800) 798-2864 (U.S.); (617) 614-6206 (international)Passcode: 87996589 (Nektar is the host)An audio replay will also be available shortly following the call through Friday, November 19, 2010 and can be accessed by dialing (888) 286-8010 (U.S.); or (617) 801-6888 (international) with a passcode of 55049373.

In the event that any non-GAAP financial measure is discussed on the conference call that is not described in the press release, or explained on the conference call, related information will be made available on the Investor Relations page at the Nektar website as soon as practical after the conclusion of the conference call.

About NektarNektar Therapeutics is a biopharmaceutical company developing novel therapeutics based on its PEGylation and advanced polymer conjugation technology platforms. Nektar has a robust R&D pipeline of potentially high-value therapeutics in oncology, pain and other areas. In the area of pain, Nektar has an exclusive worldwide license agreement with AstraZeneca for Nektar's oral NKTR-118 development
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Nektar Commences Phase 2 Clinical Development Program for NKTR-102 (PEG-Irinotecan) in Colorectal Cancer
2. Nektar Commences Phase 2 Trial of NKTR-118 (oral PEG-naloxol) Evaluating Efficacy and Safety as Treatment for Opioid-Induced Bowel Dysfunction
3. Nektar Terminates All Negotiations With Potential Partners for Inhaled Insulin; Increased Number of Lung Cancer Cases Observed in Ongoing Clinical Studies of Inhaled Insulin Patients
4. Nektar Therapeutics to Present Positive Data at Upcoming Medical and Scientific Meetings
5. Nektar to Webcast Presentation of Phase 1 Clinical Results for Lead Small Molecule PEG-Oncolytic Program, NKTR-102 (PEG-irinotecan)
6. Nektar Announces Expanded Phase 2 Clinical Development Plan For NKTR-102 (PEG-irinotecan)
7. Nektar Announces Positive Results from Phase 2 Study of Oral NKTR-118 in Patients with Opioid-Induced Constipation (OIC)
8. Nektar Therapeutics Reports Second Quarter 2009 Financial Results
9. Nektar Presents Data Demonstrating Favorable Oral Bioavailability and Drug-Drug Interaction Profile for NKTR-118
10. Nektar Therapeutics Promotes Lorianne Masuoka, M.D. to Senior Vice President and Chief Medical Officer
11. Nektar Presents New Preclinical Data on NKTR-181 at Anesthesiology 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... MOUNTAIN VIEW, Calif. , July 29, 2014 ... antivirals has amplified with rising incidence rates and ... absence of a preventative vaccine. Change is underway ... and interferon regimens towards highly effective, easily-tolerated, interferon-free ... http://photos.prnewswire.com/prnh/20140728/130662 Gilead,s mega blockbuster ...
(Date:7/29/2014)... 29, 2014  Cloud Pharmaceuticals, Inc., a therapeutics ... announced today that it has been awarded a ... Small Business Innovation Research (NSF SBIR) program. The ... Cloud Pharmaceuticals designs new drugs and drug candidates ... innovative cloud computing technology in place of traditional ...
(Date:7/29/2014)... 29, 2014  Encision Inc. (OTCQB:ECIA), a medical device ... electrosurgical burns in minimally invasive surgery, today announced financial ... 30, 2014. The Company posted quarterly net ... of $202 thousand, or $(0.02) per share. These results ... net loss of $311 thousand, or $(0.04) per share, ...
Breaking Medicine Technology:A Treatment Revolution is Underway: All-Oral Therapies Transform Global Hepatitis C Antiviral Market 2A Treatment Revolution is Underway: All-Oral Therapies Transform Global Hepatitis C Antiviral Market 3A Treatment Revolution is Underway: All-Oral Therapies Transform Global Hepatitis C Antiviral Market 4Cloud Pharmaceuticals Receives Phase I NSF SBIR Grant Valued at $150,000 2Encision Reports First Quarter Fiscal Year 2015 Results 2Encision Reports First Quarter Fiscal Year 2015 Results 3Encision Reports First Quarter Fiscal Year 2015 Results 4
... 15, 2011  SuccessEHS announces the release of the new ... equip clients with a dependable roadmap to NCQA ... the meaningful use criteria. The release of ... solution that support the patient-centered care model, and underscores ...
... Dec. 15, 2011  New York Gov. Andrew Cuomo,s pen was ... law a bill that bans Pharmacy Benefit Managers (PBMs) from ... Cuomo and the New York State Assembly showed tremendous courage ... hundreds of thousands of dollars lobbying against the new law. ...
Cached Medicine Technology:SuccessEHS Releases Patient-Centered Medical Home (PCMH) Toolkit 2SuccessEHS Releases Patient-Centered Medical Home (PCMH) Toolkit 3SuccessEHS Releases Patient-Centered Medical Home (PCMH) Toolkit 4New York's Anti-Mandatory Mail Order Law Underscores Growing Skepticism of PBMs 2
(Date:7/29/2014)... 29, 2014 A recent study ... journal Lipids in Health and Disease has added ... triglyceride-form best-selling Ultimate Omega®/ProOmega®. Consistently ranked as the ... scan data, the product was shown to be ... products in the marketplace. The goal of the ...
(Date:7/29/2014)... Bethesda, Maryland (PRWEB) July 29, 2014 ... has been named a 2014 ASAE Power of ... Flu-Focused," a public awareness campaign to encourage everyone age ... annually. , ASAE recognized NFID for its power ... drive awareness and action among consumers and professionals about ...
(Date:7/29/2014)... (PRWEB) July 29, 2014 The Eleventh ... Venture Summit concluded with the $10,000 prize being presented ... ( http://www.bikanta.com ) , The 11th Annual Summit was ... with entrepreneurs who can bring innovative products and services ... are pleased to have had such excellent array of ...
(Date:7/29/2014)... (PRWEB) July 29, 2014 Oxnard dentists ... Anacapa Dental Art Institute in Oxnard and Woodland Hills, Calif., ... fallen out or been removed due to dental disease. , ... the two prosthodontists (experts in restoring and replacing teeth) want ... using implant specialists to perform their dental work and of ...
(Date:7/29/2014)... "Acceptance, Recognition, and Control (A.R.C.) Against Depression" ... demons and wants other men to heed the call to ... month later, he had no job, leaving Raymond with a ... the government for assistance, the emotional disturbance was so great ... this approach didn’t get to the root of his problems. ...
Breaking Medicine News(10 mins):Health News:Study Shows Nordic Naturals® Triglyceride-Form Ultimate Omega®/ProOmega® More Effective Than Krill Oil, Salmon Oil, and Ethyl Ester Fish Oil 2Health News:Study Shows Nordic Naturals® Triglyceride-Form Ultimate Omega®/ProOmega® More Effective Than Krill Oil, Salmon Oil, and Ethyl Ester Fish Oil 3Health News:National Foundation for Infectious Diseases Receives Top ASAE Honors for Keeping the Nation Flu-Focused 2Health News:Silicon Valley Boomer Venture Summit Names Bikanta Competition Winner 2Health News:Oxnard Dental Implant Experts Warn of Infections Around Dental Implants 2Health News:Oxnard Dental Implant Experts Warn of Infections Around Dental Implants 3Health News:Oxnard Dental Implant Experts Warn of Infections Around Dental Implants 4Health News:SBPRA Announces the Release of Its Newest Title, "Acceptance, Recognition, and Control (A.R.C.) Against Depression" 2
... that parents who share their beds// with their newborn babies can ... infant death syndrome or SIDS is one of the major reasons ... month to a year. SIDS is a disorder that seems to ... risk factors that seem to increase the incidence of SIDS. ...
... a common condition in India where beetle and tobacco chewing ... certain bacteria’s excessive presence may give an early warning of ... in the Open Access journal, Journal of Translational Medicine has ... squamous cell carcinoma) have six common species of bacteria in ...
... women and the condition// can sometimes be fatal. Now researcher ... basal ganglia region of the brain. ,People with ... unaware of the seriousness of their condition.When you talk of ... talented singer Karen Carpenter who died in the prime of ...
... blood to indicate the possibility of heart// attack in people ... issue of New England Journal of Medicine indicates that blood ... fatty build- up patients have in their arteries of ... use of invasive tests like angiograms. ,Oxidized phospholipids ...
... study by the researchers of University of British Columbia had ... help to our concentration and efficiency, more so when that ... balance. ,Noise is often thought as the one sensation ... want to concentrate upon. Noise is often related to the ...
... good for health, especially the role of fats, had been ... University had found out that the between the various kinds ... to have the healthy meal by banishing one kind of ... The right combination of both can help achieve the best ...
Cached Medicine News:Health News:PET Scan find the Area of Brain Responsible for Anorexia Nervosa 2Health News:PET Scan find the Area of Brain Responsible for Anorexia Nervosa 3
... Finnpipette Focus from Thermo Labsystems ... ergonomics with uncompromising performance. ... offers a custom fit for ... shorter tip cones allow easier ...
2L...
Pipetman F is a fixed-volume, air-displacement pipette. Thirteen robust models cover a large volume range from 2 L to 1000 L, with Gilsons legendary accuracy and precision....
... Series 2000 Pipette is a synonym for ... and robust design, and superior operating comfort. ... operate the measuring stroke and blow-out as ... "pipette/tip" system ensures utmost accuracy and precision. ...
Medicine Products: